Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECISION
2023-509898-23-00Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of digoxin in heart failure (HF) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Composite of (repeated) heart failure hospitalizations, (repeated) urgent heart failure hospital visits and cardiovascular death. Started Oct 2024; status: completed.
02
Drugs
digoxin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2023-509898-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509898-23-00.